Peptidylarginine Deiminases: An Overview of Recent Advances in Citrullination Research
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262412060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Magdalena Kijak-Boćkowska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathomorphology, Maritime Hospital, Gdynia, 81-519 Gdynia, Poland. Hauptthemen laut MEDLINE: Citrullination, Protein-Arginine Deiminases, Citrulline. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The peptidylarginine deiminase (PAD) family includes five isozymes (PAD1–4 and PAD6) with unique tissue distributions and substrate specificities. These enzymes facilitate citrullination, a post-translational modification where positively charged arginine residues are converted into neutral citrulline residues in the presence of calcium ions. This process significantly changes protein properties, affecting molecular interactions, structural stability, and biological functions. Over the past six years (2019–2025), there has been significant progress in understanding PAD activity mechanisms and their therapeutic potential. Recent discoveries include the regulated nuclear translocation of PAD2, PAD4’s specific role in forming cancer extracellular chromatin networks (CECNs), and the development of next-generation inhibitors with greatly improved pharmacological profiles. PAD4 is crucial in forming neutrophil extracellular traps (NETs). Citrullination of histones H3 and H4 by PAD4 destabilizes chromatin, helping release DNA-protein networks as an antibacterial defense. However, excessive NET formation can contribute to autoimmune diseases and thrombosis. Similarly, the bacterial peptidylarginine deiminase from Porphyromonas gingivalis (PPAD)—the only known prokaryotic citrullinating enzyme—plays a key role. Working with R-gingipains, PPAD triggers pathological citrullination of host proteins, leading to immune tolerance breakdown and linking periodontal disease with systemic autoimmune disorders such as rheumatoid arthritis, atherosclerosis, and Alzheimer’s disease. Once thought to be a rare post-translational modification, citrullination is now understood as a vital regulatory mechanism in both normal physiology and disease, involving both internal processes of homeostasis and external mechanisms of bacterial pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathomorphology, Maritime Hospital, Gdynia, 81-519 Gdynia, Poland.
- Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
ORCID-Profile: Joanna Czerwińska, Agnieszka Owczarczyk-Saczonek
Zitieren
APA
Kijak-Boćkowska, M., Czerwińska, J., & Owczarczyk-Saczonek, A. (2025). Peptidylarginine Deiminases: An Overview of Recent Advances in Citrullination Research. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412060
Vancouver
Kijak-Boćkowska M, Czerwińska J, Owczarczyk-Saczonek A. Peptidylarginine Deiminases: An Overview of Recent Advances in Citrullination Research. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412060
BibTeX
@article{KijakBokowska2025,
author = {Kijak-Boćkowska, Magdalena and Czerwińska, Joanna and Owczarczyk-Saczonek, Agnieszka},
title = {Peptidylarginine Deiminases: An Overview of Recent Advances in Citrullination Research},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262412060}
}
EUVIMED